X-Health.show - meet the future of healthcare
Psychedelics to Treat Addiction: Dr. Dario Dornbierer, Reconnect Labs
How do you design a psychedelic trip that is predictable and effective?
That frees people from cocaine addiction
Without the common current side effects of psychedelics
Just imagine being free from an addiction in a few hours
This is what researchers and my guest today are trying to accomplish
You’ll hear
- how did psychedelic studies continue in Switzerland while banned elsewhere
- the differences between various psychedelics
- what is ayahuasca and its DMT ingredient
- how do magic mushrooms and psilocybin work
- LSD
- ecstasy
- and the potential of psychedelics in treating depression, anxiety, and cocaine addiction
My guest, Dr. Dario Dornbierer, is the Chief Scientific Officer and a co-founder of Reconnect Labs. A psychopharmacologist who’s done his post-doc research in psychedelics – drug development in mental health.
Reconnect Labs is a clinical-stage Swiss startup, a spin-off of the University of Zurich, developing psychedelic medicines for sleep, anxiety, and substance use disorders. This opens a new era in psychiatry: precision therapeutics with both immediate and long-term symptom alleviation.
Hit play to step into a sleep lab, where it all started.
Learn more about Reconnect Labs at:
https://www.reconnect-labs.com/
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.
How do you design a psychedelic trip that is predictable and effective?
That frees people from cocaine addiction
Without the common current side effects of psychedelics
Just imagine being free from an addiction in a few hours
This is what researchers and my guest today are trying to accomplish
You’ll hear
- how did psychedelic studies continue in Switzerland while banned elsewhere
- the differences between various psychedelics
- what is ayahuasca and its DMT ingredient
- how do magic mushrooms and psilocybin work
- LSD
- ecstasy
- and the potential of psychedelics in treating depression, anxiety, and cocaine addiction
My guest, Dr. Dario Dornbierer, is the Chief Scientific Officer and a co-founder of Reconnect Labs. A psychopharmacologist who’s done his post-doc research in psychedelics – drug development in mental health.
Reconnect Labs is a clinical-stage Swiss startup, a spin-off of the University of Zurich, developing psychedelic medicines for sleep, anxiety, and substance use disorders. This opens a new era in psychiatry: precision therapeutics with both immediate and long-term symptom alleviation.
Hit play to step into a sleep lab, where it all started.
Learn more about Reconnect Labs at:
https://www.reconnect-labs.com/
If you've enjoyed listening, you'll make us happy by clicking "Follow" on X-Health.show and leaving a review.
The information in this podcast is for informational purposes only and should not be considered medical advice. If you have any medical questions, please consult your healthcare practitioner. The opinions on the show are Alex's or her guests. The podcast does not make any responsibility or warranties about guests statements or credibility. While the podcast makes every effort to ensure that the information shared is accurate, please let us know if you have any comments, suggestions or corrections.